Few Japanese Patients Receive New Alzheimer's Drugs Due to Cost and Side Effects

A study in Japan reveals that less than 20% of patients interested in new Alzheimer's drugs actually received them, primarily due to ineligibility, potential side effects, and high costs.

8 Apr, 04:50 — 8 Apr, 04:50

Post Share

Sources

Showing 1 of 1 sources

japan-timesMostly Factual2d ago

Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one

Many were ineligible or decided against taking the medications due to potential side effects and the high cost, a study has found.

Read full article →

PERSPECTA

PERSPECTA

Few Japanese Patients Receive New Alzheimer's Drugs Due to Cost and Side Effects

Sources

Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one

Related Stories

Magnitude 4.1 Earthquake Strikes Off Pangasinan, Philippines

Artemis II Mission Concludes as Orion Capsule Returns to Earth

Fictional Artemis X Mission Explores Astronaut's Waiting Experience

NASA's Artemis Crew Prepares for Splashdown After Moon Voyage

PERSPECTA